HSPMdb Accession No | HSPMDB000580 |
PMID | 19195901 |
Target | Hsp70 |
HSP Name | PfHsp70 |
Organism | Plasmodium falciparum |
Localization | Cytosol and nucleus |
Cellular activity | Antiparasitic activity (inhibition of [3H]hypoxanthine uptake) |
Compound Name | MAL2-215 |
IUPAC Name | benzyl 4-{[1,1'-biphenyl]-4-yl}-1-[5-({2-[3-(methoxycarbonyl)-2-methyl-5-phenyl-1H-pyrrol-1-yl]ethyl}carbamoyl)pentyl]-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
SMILES | COC(=O)C1=C(C)N(CCNC(=O)CCCCCN2C(=O)NC(C3=CC=C(C=C3)C3=CC=CC=C3)C(C(=O)OCC3=CC=CC=C3)=C2C)C(=C1)C1=CC=CC=C1 |
Class | Pyrimidinone amide |
IC50 (µM) | 0.05 |
Cellular assay | [3H]hypoxanthine uptake assay |
Cellular Model | P. falciparum |
Disease | Malaria |